MAIA Biotechnology: director Luput Cristian received 33,536 shares

What happened

• The filing shows Luput Cristian, director, received a grant of stock options representing the right to acquire 33,536 shares of common stock. Exercise price reported as $0.00 per share; aggregate value reported as $0.00. Transaction type: derivative acquisition (A) on Sep 30, 2026.

Key details

• Transaction date and price: Sep 30, 2026; $0.00 per share.
• Filing date: Form 4 filed Oct 2, 2026.
• Shares owned after the transaction: not stated in the filing.
• Footnote F1 from the filing: the stock options, granted on Sep 30, 2026 pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, vest 100% on the date of the grant and are exercisable beginning as of that date.
• Filing timeliness: the filing does not indicate it was late.

Why it may matter

• This was an option grant (derivative award); no exercise or sale of underlying shares is reported in this Form 4.
• This filing does not show why the insider traded or why the company acted.